BLT 0.00% 2.6¢ benitec biopharma limited

Ann: OPMD Orphan Disease Program Update, page-16

  1. 536 Posts.
    lightbulb Created with Sketch. 1
    Hi Blane,

    I agree with you the press release had no real information to take our share price higher..

    It would be nice if Benitec updated the market on our cancer program because it would likely provide new information and let everyone know we are close to a human clinical trial.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.